Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. Mai 2026 10:58 ET | Quelle: Research and Markets

7MM Human Immunodeficiency Virus (HIV) Drug Forecast and Market Analysis Report 2026: Pipeline STRs Will Not Surpass Biktarvy in Terms of Commercial Success - Outlook to 2033

Dublin, May 26, 2026 (GLOBE NEWSWIRE) -- The "Human Immunodeficiency Virus (HIV): Seven-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's...
25. Mai 2026 05:31 ET | Quelle: Research and Markets

Tacrolimus Market Research Report 2026: Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2035

Dublin, May 25, 2026 (GLOBE NEWSWIRE) -- The "Tacrolimus Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. ...
21. Mai 2026 09:12 ET | Quelle: Research and Markets

Chronic Gout Market Research Report 2026-2036 - Late-stage Pipeline, Including SEL-212 and Dapansutrile Signals a New Wave of Therapies

Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Global Chronic Gout Market: Focus on Drug Class, Disease Type, Distribution Channel, Country, and Region - Analysis and Forecast, 2026-2036" report has...
19. Mai 2026 06:24 ET | Quelle: Research and Markets

Autoimmune Collaboration and Licensing Agreements Benchmark Report 2026: Direct Access to 1,000+ Real-world Partnerships Across 30+ Diseases - How Deals are Structured, Valued, Negotiated

Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Autoimmune Collaboration and Licensing Deals 2016-2026" report has been added to ResearchAndMarkets.com's offering.Autoimmune Collaboration and...
19. Mai 2026 04:34 ET | Quelle: Research and Markets

Immunology Collaboration and Licensing Agreements Benchmark Report 2026: Access to 864 Deals, Delivering a Clear and Evidence-based View of How Partnerships are Designed, Negotiated, and Executed

Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Immunology Collaboration and Licensing Deals 2018-2026" report has been added to ResearchAndMarkets.com's offering.The definitive benchmark for...
15. Mai 2026 07:39 ET | Quelle: Research and Markets

Tetraspecific Antibodies Clinical Pipeline Market research 2026: Development Technologies, Therapeutic Approaches & Market Opportunity Insight to 2032

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Tetraspecific Antibodies Clinical Pipeline, Development Technologies, Therapeutic Approaches & Market Opportunity Insight 2026" report has been...
15. Mai 2026 05:22 ET | Quelle: Research and Markets

Benlysta Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Benlysta Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The report offers insights into...
15. Mai 2026 04:19 ET | Quelle: Research and Markets

Tocilizumab Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Tocilizumab Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. Tocilizumab achieved remarkable...
15. Mai 2026 04:14 ET | Quelle: Research and Markets

COSENTYX Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "COSENTYX Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The report provides insights into...
14. Mai 2026 09:43 ET | Quelle: Research and Markets

Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of Complement C5 Inhibitors & C5 Receptor Antagonists" report has been added to ResearchAndMarkets.com's offering.This competitive...

Nächste Seite